Activity of compounds from temperate propolis against Trypanosoma brucei and Leishmania mexicana
Alotaibi, Abdullah and Ebiloma, Godwin U. and Williams, Roderick and Alfayez, Ibrahim A. and Natto, Manal J. and Alenezi, Sameah and Siheri, Weam and AlQarni, Malik and Igoli, John O. and Fearnley, James and de Koning, Harry P. and Watson, David G. (2021) Activity of compounds from temperate propolis against Trypanosoma brucei and Leishmania mexicana. Molecules, 26 (13). 3912. ISSN 1420-3049 (https://doi.org/10.3390/molecules26133912)
Preview |
Text.
Filename: Alotaibi_etal_Molecules_2021_Activity_of_compounds_from_temperate_propolis_against_Tryp_2_anosoma_brucei.pdf
Final Published Version License: Download (306kB)| Preview |
Abstract
Ethanolic extracts of samples of temperate zone propolis, four from the UK and one from Poland, were tested against three strains and displayed EC values < 20 µg/mL. The extracts were fractionated, from which 12 compounds and one two-component mixture were isolated, and characterized by NMR and high-resolution mass spectrometry, as 3-acetoxypinobanksin, tectochrysin, kaempferol, pinocembrin, 4'-methoxykaempferol, galangin, chrysin, apigenin, pinostrobin, cinnamic acid, coumaric acid, cinnamyl ester/coumaric acid benzyl ester (mixture), 4',7-dimethoxykaempferol, and naringenin 4',7-dimethyl ether. The isolated compounds were tested against drug-sensitive and drug-resistant strains of and , with the highest activities ≤ 15 µM. The most active compounds against were naringenin 4',7 dimethyl ether and 4'methoxy kaempferol with activity of 15-20 µM against the three strains. The most active compounds against were 4',7-dimethoxykaempferol and the coumaric acid ester mixture, with EC values of 12.9 ± 3.7 µM and 13.1 ± 1.0 µM. No loss of activity was found with the diamidine- and arsenical-resistant or phenanthridine-resistant strains, or the miltefosine-resistant strain; no clear structure activity relationship was observed for the isolated compounds. Temperate propolis yields multiple compounds with anti-kinetoplastid activity.
ORCID iDs
Alotaibi, Abdullah, Ebiloma, Godwin U., Williams, Roderick, Alfayez, Ibrahim A., Natto, Manal J., Alenezi, Sameah, Siheri, Weam ORCID: https://orcid.org/0000-0001-6569-7281, AlQarni, Malik, Igoli, John O., Fearnley, James, de Koning, Harry P. and Watson, David G. ORCID: https://orcid.org/0000-0003-1094-7604;-
-
Item type: Article ID code: 76831 Dates: DateEvent26 June 2021Published18 June 2021AcceptedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 18 Jun 2021 11:41 Last modified: 11 Nov 2024 13:07 URI: https://strathprints.strath.ac.uk/id/eprint/76831